Incidence and residual risk of HCV in Lithuanian blood donors from 2004 to 2018: call for screening improvement in a general population

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

A Novel Approach Continuum from Identification to Elimination in HCV-Infected Individuals on Opioid Substitution Therapy and High-Risk Populations

International Viral Hepatitis Elimination Meeting (IVHEM) 2020

Creating a Safe Space for Key Populations Within Health Facilities: Experience from Montserrado County, Liberia - Gift Kamanga

INTEREST 2020

Clinical Data from the GP120 Inhibitor Temsavir and Its Potential Relevance to Immune Reconstitution and HIV Associated Inflammation- Georg Behrens, MD, PhD

EACS 2023 Symposium - The Devil Wears GP120

INSTI exposure and neural tube defects – data from antiretroviral pregnancy registry - Jessica Albano, PhD, MPH

International Workshop on HIV & Women 2019

Mortality from Liver Diseases Associated with Hepatitis B and C in the EU/EEA – Descriptive Analysis and Estimation of 2015 Baseline- O. Mårdh

International Viral Hepatitis Elimination Meeting (IVHEM) 2019

Population pharmacokinetics and penetration of first and second line anti-TB drugs in pulmonary lesions from adults with active tuberculosis - S. Gupta

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2015

What Have We Learned from the ACT Initiative – identifying and treating children with HIV infection- George Siberry, MD, PhD

International Workshop on HIV & Pediatrics 2017

Insights from Intrahepatic Analysis in Clinical Trials for Chronic Hepatitis B -Jordan Feld, MD, MPH

International Workshop on HBV Cure 2024

Assessing HIV prevention coverage (...) Results from the PrEP APPEAL Study - Benjamin R Bavinton

APACC 2024